Use of self-interaction parameters derived from light scattering experiments for better developability assessment of biologic therapeutics

November 8, 2021

The ability to monitor biologic candidates' propensity towards self-association is considered critical for predicting whether a therapeutic is likely to aggregate or become difficult to administer due to viscosity. Because it is neither practical nor cost-effective to consume large quantities of material early in development, measurements are conducted at low concentrations and used to predict how a formulation will behave at higher, more clinically-relevant concentrations. Precise and reproducible data for these measurements is required for rational decision-making that improves downstream success. Read how Merck KGaA uses deviation from linearity derived from light scattering measurements to find the optimal formulation buffer for their biologics candidates, and how these measurements on the Prometheus Panta compare to previously collected data.

Previous Video
Prometheus Panta: The new gold standard for biologics characterization
Prometheus Panta: The new gold standard for biologics characterization

Choosing the right stability characterization tool for your biologics research is a big commitment. You’re ...

Up next
Your guide to efficiently develop antibody-based therapeutics
Your guide to efficiently develop antibody-based therapeutics

How to measure stability, why it's important, and where it belongs in the workflow

Looking for the optimal formulation for your biologics candidates?

NanoTemper tools can help

Find out how